Clinical Trial Update: Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update evaluating Phagenix's bacteriophage therapy for wound infections caused by Escherichia coli and Pseudomonas aeruginosa i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Wound Infection
• Burns
• Escherichia Coli Infection
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Phagenix phage therapy (bacteriophage therapy)

Snippet

Sponsor: Phagenix | Conditions: Wound Infection | Phase 1, Phase 2 | Status: UNKNOWN